Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7349618rdf:typepubmed:Citationlld:pubmed
pubmed-article:7349618lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7349618lifeskim:mentionsumls-concept:C0003467lld:lifeskim
pubmed-article:7349618lifeskim:mentionsumls-concept:C0027358lld:lifeskim
pubmed-article:7349618lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:7349618lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7349618pubmed:issue11lld:pubmed
pubmed-article:7349618pubmed:dateCreated1983-4-7lld:pubmed
pubmed-article:7349618pubmed:abstractTextA significant number of normal and chronically anxious subjects were able to discriminate subjectively between a session in which they received naloxone and one which they received a placebo. However, affective and physiological measures did not differ significantly between the drug and placebo sessions. The weakness of the response makes it unlikely that a naloxone-responsive endogenous opioid system is substantially involved in the regulation of anxiety. An unexpected finding from the placebo session data was that, despite increased forehead muscle tension and high self-ratings of distress, chronically anxious subjects showed consistently stable sympathetic activity under resting conditions and mild stress, indicating the existence of a subgroup of generalized anxiety patients with low autonomic reactivity.lld:pubmed
pubmed-article:7349618pubmed:languageenglld:pubmed
pubmed-article:7349618pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7349618pubmed:citationSubsetIMlld:pubmed
pubmed-article:7349618pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7349618pubmed:statusMEDLINElld:pubmed
pubmed-article:7349618pubmed:monthNovlld:pubmed
pubmed-article:7349618pubmed:issn0006-3223lld:pubmed
pubmed-article:7349618pubmed:authorpubmed-author:Hoehn-SaricRRlld:pubmed
pubmed-article:7349618pubmed:authorpubmed-author:MasekB JBJlld:pubmed
pubmed-article:7349618pubmed:issnTypePrintlld:pubmed
pubmed-article:7349618pubmed:volume16lld:pubmed
pubmed-article:7349618pubmed:ownerNLMlld:pubmed
pubmed-article:7349618pubmed:authorsCompleteYlld:pubmed
pubmed-article:7349618pubmed:pagination1041-50lld:pubmed
pubmed-article:7349618pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:meshHeadingpubmed-meshheading:7349618-...lld:pubmed
pubmed-article:7349618pubmed:year1981lld:pubmed
pubmed-article:7349618pubmed:articleTitleEffects of naloxone on normals and chronically anxious patients.lld:pubmed
pubmed-article:7349618pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7349618pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7349618pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:7349618pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7349618lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7349618lld:pubmed